Health Wire Taiwan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire Taiwan.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on February 9, 2026

Feb. 9, 2026

台灣第一家通過認證的全方位心臟衰竭中心

EIN Presswire

Feb. 9, 2026

SafeSpace Global Corp. (OTCID: SSGC) Announces Investor Day to be held in Nashville, Tennessee on February 27, 2026

GlobeNewswire

Feb. 9, 2026

DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit

GlobeNewswire

Feb. 9, 2026

DBV Technologies participeà la conférence Emerging Outlook: Biotech Summit organisée par Guggenheim Securities

GlobeNewswire

Feb. 9, 2026

DLH Reports Fiscal 2026 First Quarter Results

GlobeNewswire

Feb. 9, 2026

OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th

GlobeNewswire

Feb. 9, 2026

LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026

GlobeNewswire

Feb. 9, 2026

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 9, 2026

Earth Science Tech, Inc. (ETST), to Report Financial Results for Fiscal Third Quarter on February 17, 2026

GlobeNewswire

Feb. 9, 2026

PetVivo Sets Fiscal Third Quarter 2026 Conference Call for Monday, February 16, 2026 at 5:00 p.m. ET

GlobeNewswire

Feb. 9, 2026

Synfini Introduces Integrated Microscale Purification, Delivering Assay-Ready Compounds in Hours Instead of Days

GlobeNewswire

Feb. 9, 2026

AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors

GlobeNewswire

Feb. 9, 2026

AB Science annonce que la Food and Drug Administration (FDA) américaine a accordé le statut de Minor Use in Major Species (MUMS) au Masivet® dans le traitement des tumeurs mastocytaires chez le chien

GlobeNewswire

Feb. 9, 2026

Carterra Launches Industry’s First 48-channel HT-SPR Platform for Advanced Label-free Biomolecular Screening and Characterization

GlobeNewswire

Feb. 9, 2026

Allsup Highlights SSDI Eligibility For Heart Disease And Stroke Survivors

GlobeNewswire

Feb. 9, 2026

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Feb. 9, 2026

Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint

GlobeNewswire

Feb. 9, 2026

Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping

GlobeNewswire

Feb. 9, 2026

Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services

GlobeNewswire

Feb. 9, 2026

Palisade Bio to Participate in the Piper Sandler Virtual Novel Targets in Immunology Symposium

GlobeNewswire